Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac MRI in cardiac dystrophinopathy: recommendations on imaging.

Open heart·2026
Same author

Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry.

JAMA·2026
Same author

Sex Differences in the Genetic Causes of Dilated Cardiomyopathy.

Journal of the American College of Cardiology·2025
Same author

First-in-Human Implantable Inferior Vena Cava Sensor for Remote Care in Heart Failure: FUTURE-HF.

JACC. Heart failure·2025
Same author

CTCA Prior to Invasive Coronary Angiography in Patients With Previous Bypass Surgery: Patient-Related Outcomes, Imaging Resource Utilization, and Cardiac Events at 3 Years From the BYPASS-CTCA Trial.

Circulation. Cardiovascular interventions·2024
Same author

Genome-wide association analysis provides insights into the molecular etiology of dilated cardiomyopathy.

Nature genetics·2024
Same journal

Breast cancer and coronary artery disease: insights from a national inpatient sample analysis.

Future cardiology·2026
Same journal

Mitral valve dysplasia associated with left ventricular non-compaction cardiomyopathy and papillary muscle hypertrophy: a case report.

Future cardiology·2026
Same journal

Cardio-oncology awareness: a multidisciplinary survey among trainees and practicing professionals at multidisciplinary settings.

Future cardiology·2026
Same journal

Wearable devices for atrial fibrillation: diagnostic and screening roles of ECG and PPG-A systematic review.

Future cardiology·2026
Same journal

Impact of comorbid mental disorders on in‑hospital mortality and complications after ST‑segment elevation myocardial infarction.

Future cardiology·2026
Same journal

Endovascular revascularisation of lower-extremity peripheral arterial disease: technical and clinical outcomes in a Vietnamese single-center prospective cohort study.

Future cardiology·2026
See all related articles

Related Experiment Video

Updated: May 29, 2026

MRI and PET in Mouse Models of Myocardial Infarction
10:46

MRI and PET in Mouse Models of Myocardial Infarction

Published on: December 19, 2013

Novel imaging techniques for diffuse myocardial fibrosis.

Daniel M Sado1, Andrew S Flett, James C Moon

  • 1Department of Inherited Cardiac Disease, The Heart Hospital, 16-18 Westmoreland Street, London, W1G 8PH, UK.

Future Cardiology
|September 21, 2011
PubMed
Summary
This summary is machine-generated.

Diffuse myocardial fibrosis (DMF) assessment is crucial for cardiac disease but invasive. Noninvasive imaging methods are needed to improve diagnosis and treatment of this important cardiac marker.

More Related Videos

Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
12:15

Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease

Published on: February 8, 2022

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
07:38

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Published on: April 13, 2018

Related Experiment Videos

Last Updated: May 29, 2026

MRI and PET in Mouse Models of Myocardial Infarction
10:46

MRI and PET in Mouse Models of Myocardial Infarction

Published on: December 19, 2013

Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
12:15

Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease

Published on: February 8, 2022

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
07:38

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Published on: April 13, 2018

Area of Science:

  • Cardiology
  • Biomedical Imaging
  • Pathology

Background:

  • Diffuse myocardial fibrosis (DMF) is a significant indicator in various cardiac conditions.
  • Current assessment of DMF requires invasive myocardial biopsy, limiting its clinical utility.
  • Developing noninvasive methods for DMF evaluation is a critical unmet need in cardiology.

Purpose of the Study:

  • To review the fundamental biology of diffuse myocardial fibrosis.
  • To evaluate the efficacy of current cardiac imaging modalities in assessing DMF.
  • To forecast future advancements in noninvasive DMF detection and quantification.

Main Methods:

  • Literature review of basic DMF biology.
  • Analysis of existing studies on cardiac imaging techniques (e.g., MRI, CT, echocardiography) for DMF.
  • Synthesis of current research and expert opinion on future directions.

Main Results:

  • DMF plays a key role in the pathophysiology of numerous heart diseases.
  • Noninvasive imaging shows promise for evaluating DMF, though limitations exist.
  • Technological advancements may soon enable accurate, routine noninvasive DMF assessment.

Conclusions:

  • Accurate noninvasive assessment of diffuse myocardial fibrosis could revolutionize cardiac disease management.
  • Further research and validation of advanced imaging techniques are essential.
  • The future of DMF evaluation lies in sophisticated, noninvasive imaging modalities.